NEOGENOMICS INC Net Cash Provided by (Used in) Financing Activities in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Neogenomics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Neogenomics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $949K, a 16.3% increase year-over-year.
  • Neogenomics Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4.65M, a 2.02% increase from 2023.
  • Neogenomics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4.55M, a 61.5% decline from 2022.
  • Neogenomics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $11.8M, a 98.4% decline from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

NEOGENOMICS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $949K +$133K +16.3% Jan 1, 2025 Mar 31, 2025 10-Q 2025-04-29
Q1 2024 $816K -$563K -40.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-04-29
Q1 2023 $1.38M -$4.68M -77.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q1 2022 $6.06M -$519M -98.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $525M +$524M +84979% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $617K +$134K +27.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 $483K +$7.73M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-29
Q1 2018 -$7.25M -$10.5M -326% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 $3.2M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2013 $4.33M +$1.82M +72.7% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-13
Q1 2012 $2.51M -$544K -17.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q1 2011 $3.05M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14

NEOGENOMICS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $4.65M +$92K +2.02% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-18
2023 $4.55M -$7.28M -61.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-18
2022 $11.8M -$713M -98.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-18
2021 $725M +$490M +208% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $236M +$76.1M +47.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 $159M +$67.5M +73.4% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $92M +$96.1M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$4.1M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2013 $2.75M -$634K -18.7% Jan 1, 2013 Dec 31, 2013 10-K 2014-02-24
2012 $3.38M +$1.03M +43.5% Jan 1, 2012 Dec 31, 2012 10-K 2014-02-24
2011 $2.36M -$75K -3.08% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-24
2010 $2.43M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.